Ovarian Cancer
The company is developing tests for ovarian mass monitoring and endometriosis that it hopes will expand its addressable market beyond that targeted by OVA1.
AmoyDx, AstraZeneca Strike Ovarian Cancer Companion Diagnostic Alliance
The companies have worked together on a number of other cancer-related projects, including a companion diagnostic for the ovarian cancer treatment olaparib.
Aspira Collaborating With Baylor Genetics on Ovarian Cancer Early Detection Test
Aspira said it will bring its experience in patient sample recruitment and ovarian cancer assay development to the collaboration.
InterVenn Biosciences Raises $34M in Series B Round to Commercialize Ovarian Cancer Test
The company also announced John Leite, the former leader of clinical business development activities at Illumina, had joined the firm as chief business officer.
Myriad Genetics Expands MyChoice CDx Access Through Partnerships in Europe, China
A deal with Burning Rock will allow the test to be used in trials and clinics in China, and Myriad will license its technology to French and German pathology labs.